Today, we understand peptide transmitters to be signaling molecules that modulate neural activity. However, in 1982 little was known about neuropeptides and their role in neural communication. The influential 1982 paper by Jan and Jan reported definitive evidence that a presynaptically released neuropeptide evokes postsynaptic responses in an identified cholinergic synapse, thereby fueling a new era in neuroscience.
Neuropeptides are short polypeptides synthesized and secreted by neurons whose functional and molecular diversity contribute to a wide range of modulatory effects in vertebrate and invertebrate nervous systems [1] . They constitute an important form of neural communication that complements conventional neurotransmission, mediated by small-molecule amino acid-based neurotransmitters, such as glutamate, glycine, and GABA. Amino acid neurotransmitters, however, are generally much better understood [2, 3] . This stems in part from the diversity and complexity of neuropeptide-mediated transmission but also from basic differences in terms of spatial distribution, both intracellularly and extracellularly. First, unlike amino acid neurotransmitters, synthesis and release of neuropeptides is independent of specific synaptic specialization [1] . Second, while amino acid neurotransmitters diffuse only tens of nanometers from their release site before being rapidly degraded, neuropeptides can diffuse multiple microns, and by targeting G protein-coupled receptors with nanomolar affinities they can maintain a long extracellular half-life [1] (Figure 1 ). Progress in understanding the role of neuropeptides in modulating neural function began in the 1970s and reached a turning point with the publication of Jan and Jan in 1982 [4] . This paper presented the first conclusive, direct evidence that presynaptic activity leads to release of the neuropeptide luteinizing hormone-releasing hormone (LHRH)-like peptide and that postsynaptic action of this neuropeptide induces a delayed, slow postsynaptic potential.
At the time of this publication, it was known that neural stimulation can evoke peptide release and that exogenous addition of neuropeptides can elicit a neural response. For example, substance P's action as a neuromodulator was inferred from its expression pattern and from its release on neural stimulation [5] . There was also evidence that the biophysical characteristics of fast, amino acid neurotransmission differed from those of neuropeptide-mediated modulation. For example, in 1968 Nishi and Koketsu characterized a noncholinergic, delayed, and slow postsynaptic potential that differed from the fast, excitatory postsynaptic potential (EPSP) or inhibitory postsynaptic potentials previously described [6] . In 1978 Katayama and North showed that iontophoretic administration of substance P onto ganglion cells of guinea pig myenteric plexus induced postsynaptic depolarizing potentials with a delayed time course and lasting 10-100 s [7] . This delayed, slow postsynaptic potential became the hallmark for neuropeptidemediated modulation and the subject of many studies. However, the precise physiological distinction between amino acid neurotransmission and neuropeptide-mediated modulation remained to be established in specific neurons and synapses.
Jan and Jan used the bullfrog sympathetic ganglion to isolate peptidergic synapses and identify the role of LHRH-like peptide in mediating the delayed, slow postsynaptic potential [4] . Exploiting its electrophysiological and pharmacological accessibility, Jan and Jan used the bullfrog paravertebral sympathetic ganglion as a model system for understanding neuropeptide-mediated transmission. Preganglionic nerve fibers extend a dense network of presynaptic boutons onto ganglion cells. The high density of peptidergic synapses allowed the authors to perform reliable electrophysiological recordings of postsynaptic responses induced by preganglionic nerve stimulation. Three types of postsynaptic potential were recorded: a fast EPSP, a slow EPSP, and a late, slow EPSP. The fast EPSP and slow EPSP were eliminated by perfusion of nicotinic and muscarinic inhibitors, respectively. In this way, the authors isolated the late, slow EPSP and demonstrated that it was elicited by a molecule other than acetylcholine.
The authors radiolabeled a high density of LHRH-like molecules found in each sympathetic ganglion and used gel filtration chromatography to demonstrate that the substance had a molecular weight of 1000 g/mol, suggesting that the molecule is a peptide whose structure closely matches mammalian LHRH protein. By quantifying radiolabeled LHRH-like peptide, the authors revealed that nerve stimulation of the preganglionic chains induced the release of LHRH-like peptide in a calcium-dependent fashion. Iontophoretic injection of LHRH-like peptide onto the ganglion cell surface caused changes in membrane resistance and permeability, as well as eliciting slow depolarization similar to the delayed, slow EPSP induced by preganglionic nerve stimulation. To determine whether the
